Summary Abnormalities in neuroretinal function may play a role in the development of diabetic retinopathy. The natural course of diabetic retinal dysfunction in a group of subjects with insulin-dependent diabetes mellitus and with no apparent microvascular alterations in the retina was followed-up with fluorescein angiography and a sensitive electrophysiological technique, i.e., steady-state focal electroretinogram at the macula, for 3 years. Before the beginning and throughout our study, strict glycaemic control was maintained by three or four daily insulin injections under careful monitoring. Analysis of macular electroretinogram provided information from different neural layers. At the first examination, functional activities of postreceptoral neurons were significantly decreased with respect to those of age-matched control subjects. Diabetic patients showed a functional loss of both ganglion cell (0.53 +0.09 vs 0.42 + 0.11 ~tV; t = 5; p = 0.0001) and preganglion cell (0.51 _+ 0.13 vs 0.42 + 0.14 ~tV; t = 2.8; p = 0.007) layers. Diabetes did not alter photoreceptor activity. After 3 years, dysfunction was significantly greater in the preganglion cell layer (0.28 + 0.11 ~tV; t = 6.3; p = 0.0001). Although in some patients further impairment of ganglion cell function was shown, no significant difference was found in 3 years. Photoreceptor function remained unaltered. No vascular abnormalities in the retina were noted after 3 years in this group of patients. Metabolic control was not correlated to functional changes. Our findings suggest that the middle retinal layer is the most sensitive physiological locus of progressive diabetes-induced dysfunction in the absence of angiographically documented abnormalities. [Diabetologia (1994) 37: 911-916] Key words Retinal function, focal electroretinogram, inner retina, photoreceptors, intensive insulin therapy, diabetic retinopathy, follow-up.
The sequence of early retinal changes in diabetes is poorly defined. Clinically detectable retinopathy in subjects with IDDM develops many years after the onset of the disease. Diabetic retinopathy has traditionally been attributed to microvascular changes [1] . Little attention has been directed to the effects of diabetes on the neural retina comprised of differ-ent cell layers and of the optic visual pathway. An important question is whether the mechanisms underlying the disturbances of the diabetic retina may or may not affect retinal neurons earlier than the vessels of the microcirculation. It is presumed that the initial pathological changes which occur in the small vessels of the diabetic retina include endothelial cell and pericyte damage as a result of trypsin digest techniques [2, 3] and the breakdown of the blood-retinal barrier detected by vitreous fluorophotometry [4] . However, there are contradictory results about the documentation of these early morphologic findings [5] [6] [7] and the pathogenetic importance of these abnormalities is unclear [8] . Recently, an experimental study showed an absence of microaneurysms, acellular capillaries, or pericyte ghosts in Values are means + SD small retinal vessels at a very early stage of retinopathy [9] , Over the past few years, the neuro-ophthalmologic use of clinical electrophysiology seems to have somewhat modified the view that the initial insult to the diabetic retina is a microangiopathy. Bresnick [10] has suggested the occurrence of an early neurosensory disorder in the diabetic retina, according to previous data from psychophysical [11] [12] [13] [14] and electrophysiological [15] [16] [17] [18] [19] studies. However, not all investigators have found functional changes before the appearance of vasculopathy in the diabetic retina [20] [21] [22] .
Using a more sensitive steady-state ERG rather than a transient ERG, early and possibly reversible signs of visual alterations in retinal function have been detected after a few years of diabetes, when no microvascular changes were could be found [23] [24] [25] [26] [27] . To investigate further the specific period in which ERG changes could precede the appearance of diabetic vasculopathy in the retina, we prospectively studied the function of all retinal neuron layers using steady-state focal ERG of the macula in diabetic patients on entry into the study and again after 3 years.
Subjects and methods
Subjects. Twenty-one IDDM patients (aged 5 to 38 years) were studied. No retinopathy was found on fluorescein angiography before and after the longitudinal study, according to the first level of the Klein classification [28] (Table 1 ). Metabolic control was evaluated by measuring HbAlo levels at the time of the first ERG examination and every 3 months thereafter. Excluded from the longitudinal study were patients who had been previously treated with two or less daily injections of insulin or who showed severe and recurrent hypoglycaemia. None of the patients had any eye or systemic diseases. Patients were asked to monitor blood glucose levels using a home blood glucose monitor three or four times per day for the 3-year follow-up. Strict glycaemic control was achieved by three or four daily insulin injections and monthly blood glucose measurements by physician.
The control group consisted of 25 age-and sex-matched subjects (12 men, 13 women, mean age 21, SD 6 years) with no family history of diabetes: Since macular ERG amplitude decreases late in life, as previously reported [29, 30] showing that age may mildly affect neuroretinal function, a focal ERG was also obtained in all control subjects after 3 years.
Informed consent was obtained from each subject.
M.A.S. Di Leo et al.: Progressive retinal dysfunction in diabetes
Methods. Clinical examination (segment biomicroscopy, corrected visual acuity, applanation tonometry, direct and indirect ophthalmoscopy) was carried out on each subject. Stereofundus photography and fluorescein angiography were performed on each patient initially and after 3 years. Fluorescein angiography was performed initially and after 3 years with a professional 50 ~ fundus camera after a rapid 5-ml injection of 10 % fluorescein sodium into the antecubital vein. Angiograms were taken with ASA400 black-and-white film.
At the beginning and at the end of this longitudinal study, we used focal ERG by uniform field (flicker ERG, FERG) and alternating black-and-white bar stimuli (pattern ERG, PERG), as previously reported [25] . FERG analysis yields a first (1F) and second (2F) component; PERG only has a second component (2P) [31] [32] [33] [34] . 1F originates in the photoreceptor layer, whereas 2F and 2P represent subsets of generators in the inner retina. 2P, but not 2F, is correlated to ganglioncell function [34, 35] . A recent study has provided evidence that the 2F component, unlike 2R has multiple generators in the middle-to-inner retina and that 2F and 2P may originate, at least in part, from the same retinal layer(s) [36] . Briefly, alternating black-and-white bars had a 1.7 eyele/degree spatial frequency, a temporal frequency of 8 Hz. In our experiments the stimulus area for PERG and FERG was set at about 80 degrees 2 (a square of 9 x 9 degree centred on the fovea) at which 2R 1F and 2F components have approximately similar amplitudes [35] . Since we wanted to compare the PERG with the FERG elicited from the same retinal area, the flicker stimulus was surrounded by a background of comparable luminance in order to reduce the effects of stray light. Under these conditions FERG can be considered focal in nature [37] . To evaluate the 1F component we used a more suitable temporal frequency of 32 Hz [35] .
All subjects were able to maintain fixation from a 43-cm viewing distance on a black mark placed in the centre of the stimulus. Pupils were not dilated and had been previously measured (pupil sizes of control and diabetic subjects were not significantly different at the moment of the first ERG test and after 3 years). ERGs were monocularly recorded by means of commercially available Ag/AgC1 electrodes taped over the skin of the lower eyelid. Another similar electrode placed over the eyelid of the contralateral unstimulated eye was used as reference (interocular ERG; [38] ). Retinal signals were band-pass filtered between 1 and 100 Hz, amplified 100,000 fold and averaged up to 800 responses by an IBM PC/XT computer, allowing rejection of single sweeps disturbed by artifacts. Discrete Fourier series of the averaged responses [39] were performed off-line to isolate the main harmonic components of PERG (i.e., 2P), and FERG (i.e., 1F and 2F). The peak-to-peak amplitude [in microvolts (~tV)] and phase in degrees of each of three components was evaluated. Each test was repeated at least twice to verify reproducibility. Amplitude and phase responses were simultaneously measured for FERG as successively for PERG. The average variation in amplitude between the two samples was 5 %; mean amplitudes of the early and late tests were not significantly different.
A fasting blood sample to measure HbAlc values was drawn from each patient in the morning of the ERG tests and at 3-month intervals for the 3-year follow-up. HbA~ c was measured with an automated HbAI~ analyser (HA 8110, Menarini Diagnostici, Firenze, Italy) by ttPLC with 5.8 % as the upper limit of the normal range. 
Statistical analysis
Results are presented as means + SD. Before statistical analysis, we calculated the intereye correlation for each subject. We considered only the right eye amplitudes in control subjects, because the paired eyes were positively correlated. On the contrary, the inter eye correlation in our diabetic group was not significant. We therefore used a two-eye statistical analysis according to Ederer [40] and Ray and O'Day [41] , because paired eyes contribute the same amount of information as unpaired eyes. Unpaired Student's t-test, paired t-test, and multiple and linear regression analyses were also used.
Results
At the time of the first and the last tests there was no significant difference between diabetic and control groups for sex and age.
At the beginning of the study and after the period of 3 years, no microvascular abnormalities were found in diabetic subjects by fluorescein angiography. Table 2 shows that the mean 2F and 2P component responses after the first test were significantly reduced in diabetic patients compared with the control group (2F: unpaired t test = 2.8, p = 0.007; 2P: t = 5, p = 0.0001); 1F was not significantly altered. After 3 years, means of focal ERG components in the non-diabetic group were not significantly reduced (paired t = 1.8;p = NS). The mean 2F amplitude of diabetic patients (paired t = 6.3;p = 0.0001), but not the mean 2P amplitude of the same group, was significantly reduced. Figure i shows 2F and 2P findings in each eye of the diabetic patients. Although there is also a trend towards visual function impairment for 2P component, many ganglion cell activities of diabetic eyes had only slightly deteriorated after 3 years. No significant modification of 1F responses in each eye of the diabetic patients was found at 3 years (Fig. 2) . Figure 3 shows that variations of 2F responses were significantly correlated with those of 2P recordings (r = 0.39, p < 0.0001). No correlation was found between HbA 1 c values and responses of PERG and FERG.
No significant differences in each component phase were noted in normal and diabetic subjects either before or after the 3-year follow-up. 
Discussion
The retina is a complex structure comprising two different vascular systems and several neural layers, including retinal pigment epithelium, photoreceptors, bipolar cells, ganglion cells, and other neurons. Although diabetic retinopathy is frequently considered a vasculopathy, the vascular component is only a small portion of the retina. This consists mainly of neural tissue, the activity of which is revealed by ERG techniques. With focal ERG, it is possible to provide information from the central retina, i.e., the macula, which has higher neuronal density than peripheral retina [32] [33] [34] . Some papers have shown that the pattern and focal ERG can become abnormal in diabetes before the onset of any visible vasculopathy [ [23] [24] [25] [26] [27] . Experimental [32, 42] and clinical [32] [33] [34] studies showed that 1F, 2F, and 2P components of a steady-state focal ERG arise from different retinal neurons. Using this technique, which was first performed in different retinal disorders [35] , we have found a gradual loss of postreceptor neuronal function as a result of diabetes, despite intensive insulin therapy and good metabolic control as reported by mean HbAlc levels during the 3-year follow-up. On the other hand, although the benefits of intensive therapy with respect to conventional therapy are unquestionable [43] , irreversible or transient worsening of retinopathy can be found, as described in previous studies [44, 45] . The three component phases were unchanged throughout this investigation, and although the 2F phase tended to be delayed in our patients, its mean values were not statistically different in IDDM and control subjects.
Retinal function impairment may be related to a higher incidence of hypoglycaemic episodes in our intensive-therapy diabetic patients. Hypoglycaemia is potentially dangerous because the tissues of the central nervous system are exclusively dependent on glucose as a metabolic fuel [46] . Some studies have shown neurophysiological alterations during and immediately after the hypoglycaemic period [47, 48] . The possibility that repeated hypoglycaemic episodes may impair glucose utilization in the inner retina (as revealed by a decrease of 2F and 2P amplitudes), without diminishing the activity of photoreceptors which receive a higher blood flow from the choroidal circulation cannot be ruled out. Recently, Skrandies and Heinrich [49] found an increase of ERG amplitude correlated to photoreceptors in reponse to hypoglycaemia.
In this study, the duration of follow-up could be too short to detect long-term effects of near-normo-M.A.S. Di Leo et al.: Progressive retinal dysfunction in diabetes glycaemia on both the deterioration of retinal neuron activity and the development of diabetic retinopathy. Engerman and Kern [50] found that the appearance of retinopathy in diabetic dogs was not related to present control but to previous hyperglycaemia. The findings of this study may provide information about the long phase preceding diabetic retinopathy: a silent process in the diabetic retina which may involve both neural and vascular structures persists for several years before clinical vasculopathy can be detected. Whether neuroretinal abnormalities may in turn lead to an increased vulnerability of the retinal microvasculature in diabetes is to be ascertained. A recent study ascribed the development of diabetic vasculopathy in the retina to abnormalities of the surrounding milieu [51] .
Some authors concluded on the basis of the techniques used, that vascular alterations in the diabetic retina were an earlier event than neurosensory dysfunction [52, 53] . However, in diabetic animals some authors found evidence that the disease affects retinal metabolism independently from vascular disease [54, 55] . Until now, the inability to clinically demonstrate neural abnormalities in the diabetic retina may be due to inadequacy of the means at our disposal. Improvement in electrodiagnostic tests can allow clinical recording of both the electrical response of the entire retina and the neuronal activities of distinct layers (receptoral to post-receptoral).
Further studies performed on larger numbers of patients and longer-term follow-up may provide more information on this relationship.
In conclusion, our study suggests that in IDDM patients under strict metabolic control neuronal function of the innermost retina before clinically detectable vascular abnormalities occurred was surprisingly impaired after only a few years of disease. It remains unclear whether the retinal dysfunction found in eyes with angiographically normal fundus represents a stage of pre-retinopathy related either to focal regions with non-vascular metabolic abnormalities or to localised areas of invisible defective capillary circulation.
